Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07770087Completed
Randomised trial of metformin 1% gel in peri-implantitis (2 arms), sponsored by Al-Azhar University. Primary endpoint: Peri-implant Bone Density at 12 months. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07770087.